Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The report for the Alpha Thalassemia Mutation Screening Test (3 Common Mutation) can be obtained within 7-10 business days from the date of sample collection.

What are the prerequisites for the test Alpha Thalassemia Mutation Screening Test (3 Common Mutation)

  • Complete blood count (CBC) test
  • Hemoglobin electrophoresis test
  • Family history of alpha thalassemia

What are the measure values for the test Alpha Thalassemia Mutation Screening Test (3 Common Mutation)

  • Deletion (-α3.7): Positive if present
  • Deletion (-α4.2): Positive if present
  • Non-Deletion HBA1/HBA2: Positive if present

What does this test Alpha Thalassemia Mutation Screening Test (3 Common Mutation) identify?

Alpha Thalassemia Mutation Screening Test (3 Common Mutation)

The Alpha Thalassemia Mutation Screening Test is a diagnostic test that identifies the presence of three common mutations associated with alpha thalassemia, a genetic disorder that affects the production of hemoglobin.

The test specifically targets the following mutations:

  • Alpha thalassemia type 1 mutation
  • Alpha thalassemia type 2 mutation
  • Alpha thalassemia type 3 mutation

Identifying these mutations can help healthcare providers determine the severity of the alpha thalassemia and develop appropriate treatment plans for individuals affected by the disorder.

Why is this test Alpha Thalassemia Mutation Screening Test (3 Common Mutation) taken?

The Alpha Thalassemia Mutation Screening Test is taken to detect the presence of three common mutations associated with Alpha Thalassemia, a genetic disorder that affects the production of hemoglobin. These mutations include the deletion of a specific gene on chromosome 16 that leads to reduced or absent production of alpha globin chains.

Individuals who are carriers of these mutations may not exhibit any symptoms, but they can pass the mutated genes on to their children, increasing the risk of having a child with more severe forms of Alpha Thalassemia. Therefore, this test is often recommended for couples who are planning to have children or for individuals with a family history of Alpha Thalassemia.

No FAQs available.

Customer Google Rating